2-127701943-G-A

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate

The NM_032740.4(SFT2D3):​c.415G>A​(p.Glu139Lys) variant causes a missense change. The variant allele was found at a frequency of 0.000107 in 1,416,598 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000080 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00011 ( 1 hom. )

Consequence

SFT2D3
NM_032740.4 missense

Scores

1
2
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 3.63

Publications

0 publications found
Variant links:
Genes affected
SFT2D3 (HGNC:28767): (SFT2 domain containing 3) Predicted to be involved in protein transport and vesicle-mediated transport. Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]
WDR33 (HGNC:25651): (WD repeat domain 33) This gene encodes a member of the WD repeat protein family. WD repeats are minimally conserved regions of approximately 40 amino acids typically bracketed by gly-his and trp-asp (GH-WD), which may facilitate formation of heterotrimeric or multiprotein complexes. Members of this family are involved in a variety of cellular processes, including cell cycle progression, signal transduction, apoptosis, and gene regulation. This gene is highly expressed in testis and the protein is localized to the nucleus. This gene may play important roles in the mechanisms of cytodifferentiation and/or DNA recombination. Multiple alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.09177813).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SFT2D3NM_032740.4 linkc.415G>A p.Glu139Lys missense_variant Exon 1 of 1 ENST00000310981.6 NP_116129.3 Q587I9
WDR33NM_018383.5 linkc.*4380C>T 3_prime_UTR_variant Exon 22 of 22 ENST00000322313.9 NP_060853.3 Q9C0J8-1
WDR33XM_011511436.2 linkc.*4380C>T 3_prime_UTR_variant Exon 22 of 22 XP_011509738.1 Q9C0J8-1
WDR33XM_005263697.4 linkc.*4550C>T 3_prime_UTR_variant Exon 21 of 21 XP_005263754.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SFT2D3ENST00000310981.6 linkc.415G>A p.Glu139Lys missense_variant Exon 1 of 1 6 NM_032740.4 ENSP00000310803.3 Q587I9
WDR33ENST00000322313.9 linkc.*4380C>T 3_prime_UTR_variant Exon 22 of 22 1 NM_018383.5 ENSP00000325377.3 Q9C0J8-1

Frequencies

GnomAD3 genomes
AF:
0.0000796
AC:
12
AN:
150734
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000178
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000117
AC:
5
AN:
42602
AF XY:
0.0000389
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000147
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000239
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000110
AC:
139
AN:
1265756
Hom.:
1
Cov.:
31
AF XY:
0.000124
AC XY:
77
AN XY:
623112
show subpopulations
African (AFR)
AF:
0.0000405
AC:
1
AN:
24682
American (AMR)
AF:
0.000117
AC:
2
AN:
17078
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19836
East Asian (EAS)
AF:
0.00
AC:
0
AN:
26526
South Asian (SAS)
AF:
0.00
AC:
0
AN:
65598
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
31578
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3662
European-Non Finnish (NFE)
AF:
0.000119
AC:
122
AN:
1024958
Other (OTH)
AF:
0.000270
AC:
14
AN:
51838
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
10
19
29
38
48
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000796
AC:
12
AN:
150842
Hom.:
0
Cov.:
33
AF XY:
0.0000136
AC XY:
1
AN XY:
73694
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41408
American (AMR)
AF:
0.00
AC:
0
AN:
15172
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3450
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10002
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.000178
AC:
12
AN:
67498
Other (OTH)
AF:
0.00
AC:
0
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000712
Hom.:
0
Bravo
AF:
0.0000491
ExAC
AF:
0.0000774
AC:
2

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Aug 10, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.415G>A (p.E139K) alteration is located in exon 1 (coding exon 1) of the SFT2D3 gene. This alteration results from a G to A substitution at nucleotide position 415, causing the glutamic acid (E) at amino acid position 139 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.20
BayesDel_addAF
Benign
-0.38
T
BayesDel_noAF
Benign
-0.49
CADD
Benign
21
DANN
Uncertain
0.99
DEOGEN2
Benign
0.0037
T
Eigen
Benign
-0.46
Eigen_PC
Benign
-0.52
FATHMM_MKL
Benign
0.51
D
LIST_S2
Benign
0.65
T
M_CAP
Benign
0.054
D
MetaRNN
Benign
0.092
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Uncertain
2.3
M
PhyloP100
3.6
PrimateAI
Pathogenic
0.92
D
PROVEAN
Benign
-0.59
N
REVEL
Benign
0.097
Sift
Benign
0.82
T
Sift4G
Benign
0.64
T
Polyphen
0.82
P
Vest4
0.34
MutPred
0.61
Gain of methylation at E139 (P = 0.0134);
MVP
0.40
ClinPred
0.23
T
GERP RS
1.6
PromoterAI
-0.016
Neutral
Varity_R
0.11
gMVP
0.34
Mutation Taster
=94/6
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs546376182; hg19: chr2-128459517; COSMIC: COSV59256276; API